Background: Continuous renal replacement therapy (CRRT) is the standard treatment for severe acute kidney injury in critically ill patients. However, a practical consensus for discontinuing CRRT is lacking. We aimed to develop a prediction model with simple clinical parameters for successful discontinuation of CRRT. Methods: Adult patients who received CRRT at Samsung Medical Center from 2007 to 2017 were included. Patients with preexisting ESRD and patients who progressed to ESRD within 1 year or died within 7 days after CRRT were excluded. Successful discontinuation of CRRT was defined as no requirement for renal replacement therapy for 7 days after discontinuing CRRT. Patients were assigned to either a success group or failure group according to whether discontinuation of CRRT was successful or not. Results: A total of 1,158 patients were included in the final analyses. The success group showed greater urine output on the day before CRRT discontinuation (D-1) and the discontinuation day (D0). Multivariable analysis identified that urine output ≥300 mL on D-1, and mean arterial pressure 50∼78 mm Hg, serum potassium <4.1 mmol/L, and BUN <35 mg/dL (12.5 mmol/L) on D0 were predictive factors for successful discontinuation of CRRT. A scoring system using the 4 variables above (area under the receiver operating curve: 0.731) was developed. Conclusions: Scoring system composed of urine output ≥300 mL/day on D-1, and adequate blood pressure, serum potassium <4.1 mmol/L, and BUN <35 mg/dL (12.5 mmol/L) on D0 was developed to predict successful discontinuation of CRRT.

1.
Susantitaphong
P
,
Cruz
DN
,
Cerda
J
,
Abulfaraj
M
,
Alqahtani
F
,
Koulouridis
I
,
World incidence of AKI: a meta-analysis
.
Clin J Am Soc Nephrol
.
2013 Sep
;
8
(
9
):
1482
93
. .
2.
Uchino
S
,
Kellum
JA
,
Bellomo
R
,
Doig
GS
,
Morimatsu
H
,
Morgera
S
,
Acute renal failure in critically ill patients: a multinational, multicenter study
.
JAMA
.
2005 Aug 17
;
294
(
7
):
813
8
. .
3.
Hoste
EA
,
Bagshaw
SM
,
Bellomo
R
,
Cely
CM
,
Colman
R
,
Cruz
DN
,
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
.
Intensive Care Med
.
2015 Aug
;
41
(
8
):
1411
23
. .
4.
van Bommel
EF
,
Ponssen
HH
.
Intermittent versus continuous treatment for acute renal failure: where do we stand?
Am J Kidney Dis
.
1997 Nov
;
30
(
5 Suppl 4
):
S72
9
. .
5.
De Vriese
AS
,
Colardyn
FA
,
Philippé
JJ
,
Vanholder
RC
,
De Sutter
JH
,
Lameire
NH
.
Cytokine removal during continuous hemofiltration in septic patients
.
J Am Soc Nephrol
.
1999 Apr
;
10
(
4
):
846
53
.
6.
Clark
WR
,
Mueller
BA
,
Kraus
MA
,
Macias
WL
.
Extracorporeal therapy requirements for patients with acute renal failure
.
J Am Soc Nephrol
.
1997 May
;
8
(
5
):
804
12
.
7.
Bonnassieux
M
,
Duclos
A
,
Schneider
AG
,
Schmidt
A
,
Bénard
S
,
Cancalon
C
,
Renal replacement therapy modality in the ICU and renal recovery at hospital discharge
.
Crit Care Med
.
2018 Feb
;
46
(
2
):
e102
e10
. .
8.
Vanholder
R
,
Van Biesen
W
,
Lameire
N
.
What is the renal replacement method of first choice for intensive care patients?
J Am Soc Nephrol
.
2001 Feb
;
12
(
Suppl 17
):
S40
3
.
9.
Gaudry
S
,
Chaïbi
K
,
Bénichou
N
,
Verney
C
,
Hajage
D
,
Dreyfuss
D
.
[Renal replacement therapy for acute kidney injury in the intensive care unit]
.
Nephrol Ther
.
2017 Apr
;
13
(
Suppl 1
):
S13
21
. .
10.
Lai
TS
,
Shiao
CC
,
Wang
JJ
,
Huang
CT
,
Wu
PC
,
Chueh
E
,
Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials
.
Ann Intensive Care
.
2017 Dec
;
7
(
1
):
38
. .
11.
Barbar
SD
,
Dargent
A
,
Quenot
JP
.
Timing of renal-replacement therapy in acute kidney injury and sepsis
.
N Engl J Med
.
2019 Jan 24
;
380
(
4
):
399
. .
12.
Bagshaw
SM
,
Chakravarthi
MR
,
Ricci
Z
,
Tolwani
A
,
Neri
M
,
De Rosa
S
,
Precision continuous renal replacement therapy and solute control
.
Blood Purif
.
2016
;
42
(
3
):
238
47
. .
13.
Ricci
Z
,
Ronco
C
.
Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis
.
Crit Care Med
.
2008 Apr
;
36
(
4 Suppl
):
S229
37
. .
14.
Uchino
S
,
Bellomo
R
,
Morimatsu
H
,
Morgera
S
,
Schetz
M
,
Tan
I
,
Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study
.
Crit Care Med
.
2009 Sep
;
37
(
9
):
2576
82
. .
15.
Wu
VC
,
Ko
WJ
,
Chang
HW
,
Chen
YW
,
Lin
YF
,
Shiao
CC
,
Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy
.
Intensive Care Med
.
2008 Jan
;
34
(
1
):
101
8
. .
16.
Al Saadon
A
,
Katulka
R
,
Sebastianski
M
,
Featherstone
R
,
Vandermeer
B
,
Gibney
RTN
,
Determining the optimal time for liberation from renal replacement therapy in critically ill patients: protocol for a systematic review and meta-analysis (DOnE RRT)
.
BMJ Open
.
2018 Nov 25
;
8
(
11
):
e023306
. .
17.
Heise
D
,
Gries
D
,
Moerer
O
,
Bleckmann
A
,
Quintel
M
.
Predicting restoration of kidney function during CRRT-free intervals
.
J Cardiothorac Surg
.
2012 Jan 18
;
7
:
6
. .
18.
Yoshida
T
,
Matsuura
R
,
Komaru
Y
,
Miyamoto
Y
,
Yoshimoto
K
,
Hamasaki
Y
,
Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation
.
Nephrology
.
2019 Mar
;
24
(
3
):
287
93
. .
19.
Katayama
S
,
Uchino
S
,
Uji
M
,
Ohnuma
T
,
Namba
Y
,
Kawarazaki
H
,
Factors predicting successful discontinuation of continuous renal replacement therapy
.
Anaesth Intensive Care
.
2016 Jul
;
44
(
4
):
453
7
. .
20.
Dünser
MW
,
Takala
J
,
Ulmer
H
,
Mayr
VD
,
Luckner
G
,
Jochberger
S
,
Arterial blood pressure during early sepsis and outcome
.
Intensive Care Med
.
2009 Jul
;
35
(
7
):
1225
33
. .
21.
Badin
J
,
Boulain
T
,
Ehrmann
S
,
Skarzynski
M
,
Bretagnol
A
,
Buret
J
,
Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study
.
Crit Care
.
2011
;
15
(
3
):
R135
. .
22.
Poukkanen
M
,
Wilkman
E
,
Vaara
ST
,
Pettilä
V
,
Kaukonen
KM
,
Korhonen
AM
,
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study
.
Crit Care
.
2013 Dec 13
;
17
(
6
):
R295
. .
23.
Asfar
P
,
Meziani
F
,
Hamel
JF
,
Grelon
F
,
Megarbane
B
,
Anguel
N
,
High versus low blood-pressure target in patients with septic shock
.
N Engl J Med
.
2014 Apr 24
;
370
(
17
):
1583
93
. .
24.
Lamontagne
F
,
Meade
MO
,
Hébert
PC
,
Asfar
P
,
Lauzier
F
,
Seely
AJE
,
Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial
.
Intensive Care Med
.
2016 Apr
;
42
(
4
):
542
50
. .
25.
Post
EH
,
Vincent
JL
.
Renal autoregulation and blood pressure management in circulatory shock
.
Crit Care
.
2018 Mar 22
;
22
(
1
):
81
. .
26.
Post
EH
,
Su
F
,
Righy Shinotsuka
C
,
Taccone
FS
,
Creteur
J
,
De Backer
D
,
Renal autoregulation in experimental septic shock and its response to vasopressin and norepinephrine administration
.
J Appl Physiol
.
2018 Sep 27
.
27.
Kiil
F
,
Kjekshus
J
,
Löyning
E
.
Renal autoregulation during infusion of noradrenaline, angiotensin and acetylcholine
.
Acta Physiol Scand
.
1969 May–Jun
;
76
(
1
):
10
23
. .
28.
Bagshaw
SM
,
Delaney
A
,
Haase
M
,
Ghali
WA
,
Bellomo
R
.
Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis
.
Crit Care Resusc
.
2007 Mar
;
9
(
1
):
60
8
.
29.
van der Voort
PH
,
Boerma
EC
,
Koopmans
M
,
Zandberg
M
,
de Ruiter
J
,
Gerritsen
RT
,
Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial
.
Crit Care Med
.
2009 Feb
;
37
(
2
):
533
8
. .
30.
Jeon
J
,
Kim
DH
,
Baeg
SI
,
Lee
EJ
,
Chung
CR
,
Jeon
K
,
Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury
.
Crit Care
.
2018 Oct 10
;
22
(
1
):
255
. .
31.
van der Voort
PH
,
Boerma
EC
,
Pickkers
P
.
The furosemide stress test to predict renal function after continuous renal replacement therapy
.
Crit Care
.
2014 May 14
;
18
(
3
):
429
. .
32.
Bouchard
J
,
Soroko
SB
,
Chertow
GM
,
Himmelfarb
J
,
Ikizler
TA
,
Paganini
EP
,
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury
.
Kidney Int
.
2009 Aug
;
76
(
4
):
422
7
. .
33.
Rifkin
DE
,
Coca
SG
,
Kalantar-Zadeh
K
.
Does AKI truly lead to CKD?
J Am Soc Nephrol
.
2012 Jun
;
23
(
6
):
979
84
. .
34.
Go
AS
,
Chertow
GM
,
Fan
D
,
McCulloch
CE
,
Hsu
CY
.
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
.
N Engl J Med
.
2004 Sep 23
;
351
(
13
):
1296
305
. .
35.
Leung
KC
,
Tonelli
M
,
James
MT
.
Chronic kidney disease following acute kidney injury-risk and outcomes
.
Nat Rev Nephrol
.
2013 Feb
;
9
(
2
):
77
85
. .
36.
Lewington
AJ
,
Cerdá
J
,
Mehta
RL
.
Raising awareness of acute kidney injury: a global perspective of a silent killer
.
Kidney Int
.
2013 Sep
;
84
(
3
):
457
67
. .
37.
Farese
S
,
Jakob
SM
,
Kalicki
R
,
Frey
FJ
,
Uehlinger
DE
.
Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration
.
Artif Organs
.
2009 Aug
;
33
(
8
):
634
40
. .
38.
Rauf
AA
,
Long
KH
,
Gajic
O
,
Anderson
SS
,
Swaminathan
L
,
Albright
RC
.
Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis
.
J Intensive Care Med
.
2008 May–Jun
;
23
(
3
):
195
203
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.